glp-1 substance use disorder GLP1 receptor agonists are supported by preclinical and observational evidence for reducing addictive behaviors, particularly alcohol and nicotine use. Initial randomized clinical trials indicate possible reductions in craving and intake, though Not just obesity: GLP-1 receptor

Cyanocobalamin is a man-made form of vitamin B12

amka M, Ruchaa M, Walkowiak J

More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/2026 1 , while around 2.5 million people each month accessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of the Digital Clinical Excellence (DiCE) network of primary care digital health providers

Many people turn to skin-brightening creams or serums to improve their complexion but these topical solutions often fall short

Understanding the balance among diet, lifestyle, and supplementation is key to effectively managing GLP-1-related health outcomes

Together, we can help you maximize your results and embrace a healthier, more vibrant future